PL345267A1 - Recombinant human interferon beta-1a (ifn-beta-1a) formulation - Google Patents

Recombinant human interferon beta-1a (ifn-beta-1a) formulation

Info

Publication number
PL345267A1
PL345267A1 PL34526798A PL34526798A PL345267A1 PL 345267 A1 PL345267 A1 PL 345267A1 PL 34526798 A PL34526798 A PL 34526798A PL 34526798 A PL34526798 A PL 34526798A PL 345267 A1 PL345267 A1 PL 345267A1
Authority
PL
Poland
Prior art keywords
beta
ifn
formulation
recombinant human
human interferon
Prior art date
Application number
PL34526798A
Inventor
John Alam
Mark Rogge
Susan Goelz
Original Assignee
Biogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen filed Critical Biogen
Priority to PL34526798A priority Critical patent/PL345267A1/en
Publication of PL345267A1 publication Critical patent/PL345267A1/en

Links

PL34526798A 1998-05-29 1998-05-29 Recombinant human interferon beta-1a (ifn-beta-1a) formulation PL345267A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL34526798A PL345267A1 (en) 1998-05-29 1998-05-29 Recombinant human interferon beta-1a (ifn-beta-1a) formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL34526798A PL345267A1 (en) 1998-05-29 1998-05-29 Recombinant human interferon beta-1a (ifn-beta-1a) formulation

Publications (1)

Publication Number Publication Date
PL345267A1 true PL345267A1 (en) 2001-12-03

Family

ID=20078222

Family Applications (1)

Application Number Title Priority Date Filing Date
PL34526798A PL345267A1 (en) 1998-05-29 1998-05-29 Recombinant human interferon beta-1a (ifn-beta-1a) formulation

Country Status (1)

Country Link
PL (1) PL345267A1 (en)

Similar Documents

Publication Publication Date Title
IL136326A0 (en) Human interferon-epsilon: a type i interferon
GB2248550B (en) hPTH (1-36) Peptides,their preparation and pharmaceutical compositions
GB9303023D0 (en) Flavivirus recombinant poxvirus vaccine
HUP0100100A3 (en) Hepatitis c inhibitor peptide analogues, pharmaceutical compositions comprising thereof and their use
IL141586A0 (en) Cyclic prosaposin-derived peptide and uses thereof
HRP950612B1 (en) PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
IL133686A0 (en) Glycoprotein hormone analogs, their preparation and use
PL341423A1 (en) Ifnar2/ifn complex
HK1030150A1 (en) Oromucosal cytokine compositions and uses thereof
IL125908A (en) Peptides and pharmaceutical compositions comprising same
EP1012262A4 (en) Human frezzled-like protein
EP0970965A4 (en) Cyclic peptides and medicinal use thereof
AU8168898A (en) Interferon stimulating protein and uses thereof
EE200000694A (en) Formulation of recombinant human iterferon beta-1a (IFN-β-1a)
GB2336844B (en) Anti-hiv peptides and proteins
PL345267A1 (en) Recombinant human interferon beta-1a (ifn-beta-1a) formulation
AU2232399A (en) Recombinant ctb-based vaccines
PL344349A1 (en) Human protein c polypeptide
AU4425797A (en) Novel human interferon-inducible protein
IL112094A0 (en) Novel peptides and pharmaceutical compositions comprising them
AU5369296A (en) Human cytokine polypeptide
ZA984103B (en) Immunopotentiating composition
SI1037658T1 (en) Ifnar/ifn complex
IL115518A0 (en) Peptides and pharmaceutical compositions comprising them
SI1077068T1 (en) Utilization of interferon alpha 5 in the treatment of viral hepatopathies